Liquid biopsies

OTHER4 trials

Sponsors

Medical University of Vienna, Universiteit Antwerpen, University Hospital, Antwerp, Academisch Medisch Centrum

Conditions

Neuroendocrine TumorsProstate Cancerbraintumors

Unknown Phase

' Biomarkers for minimal residual disease in neuro-oncology ': MIRDINO study

Academisch Medisch Centrumbraintumors

Target: 400Updated: 2024-02-28

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

WithdrawnNCT05245435

Medical University of ViennaProstate Cancer

Start: 2022-04-30End: 2024-09-30Updated: 2023-03-20

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients with an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment

CompletedNCT05255133

Universiteit AntwerpenNeuroendocrine Tumors

Start: 2017-10-09End: 2022-06-23Updated: 2025-01-06

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

University Hospital, AntwerpNeuroendocrine Tumors

Start: 2019-05-27End: 2025-12-31Target: 100Updated: 2022-03-07